BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 71 filers reported holding BLUEPRINT MEDICINES CORP in Q3 2015. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,029 | +12.2% | 20,502 | +41.2% | 0.00% | 0.0% |
| Q2 2023 | $917 | +6953.8% | 14,524 | +4908.3% | 0.00% | – |
| Q1 2023 | $13 | -100.0% | 290 | -88.7% | 0.00% | – |
| Q1 2022 | $164,000 | +241.7% | 2,569 | +366.2% | 0.00% | – |
| Q3 2021 | $48,000 | 0.0% | 551 | 0.0% | 0.00% | – |
| Q2 2021 | $48,000 | – | 551 | +8.5% | 0.00% | – |
| Q4 2020 | $0 | -100.0% | 508 | +408.0% | 0.00% | – |
| Q1 2020 | $5,000 | -96.9% | 100 | -95.5% | 0.00% | – |
| Q3 2019 | $161,000 | -43.3% | 2,198 | -51.0% | 0.00% | -100.0% |
| Q2 2018 | $284,000 | +195.8% | 4,484 | +249.2% | 0.00% | -75.0% |
| Q4 2017 | $96,000 | -41.5% | 1,284 | -68.7% | 0.00% | -42.9% |
| Q1 2017 | $164,000 | +1540.0% | 4,106 | +1009.7% | 0.01% | +600.0% |
| Q3 2016 | $10,000 | +900.0% | 370 | +386.8% | 0.00% | – |
| Q2 2016 | $1,000 | -96.3% | 76 | -92.6% | 0.00% | -100.0% |
| Q4 2015 | $27,000 | +800.0% | 1,026 | +460.7% | 0.00% | – |
| Q3 2015 | $3,000 | – | 183 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 716,539 | $36,192,000 | 12.35% |
| CADIAN CAPITAL MANAGEMENT, LP | 2,020,629 | $102,062,000 | 6.89% |
| Casdin Capital, LLC | 1,150,000 | $58,087,000 | 4.91% |
| DAFNA Capital Management LLC | 261,280 | $13,197,000 | 3.60% |
| Nextech Invest Ltd. | 188,228 | $9,507,000 | 3.21% |
| Eagle Health Investments LP | 170,551 | $8,615,000 | 2.01% |
| Boxer Capital, LLC | 507,374 | $25,627,000 | 1.62% |
| Rock Springs Capital Management LP | 979,174 | $49,458,000 | 1.44% |
| EFG Asset Management (North America) Corp. | 130,454 | $6,589,000 | 1.39% |
| Integral Health Asset Management, LLC | 130,000 | $6,566,000 | 1.35% |